Skip to main content
. Author manuscript; available in PMC: 2025 Feb 1.
Published in final edited form as: Am J Med. 2023 Nov 3;137(2):163–171.e24. doi: 10.1016/j.amjmed.2023.10.024

Table 3a:

Bivariate and Multivariable analysisa of the relationship between baseline BMI categories and clinical outcomes.

Death/MI Death CV Death MI
BMI category (kg/m2) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Bivariate Analysis
<25 ref ref ref ref
25- <30 1.27
(0.93,1.75)		 1.22
(0.85,1.75)		 1.11
(0.74,1.64)		 1.25
(0.74,2.10)
≥30 1.45
(1.06,1.96)		 1.31
(0.92,1.86)		 1.25
(0.86,1.84)		 1.81
(1.12,2.92)
Multivariable Analysis
<25 ref ref ref ref
25- <30 1.3
(0.92, 1.85)		 1.38
(0.93,2.06)		 1.07
(0.6, 1.9)		 1.21
(0.78, 1.88)
≥30 1.43
(1.00, 2.04)		 1.42
(0.94,2.15)		 1.29
(0.73, 2.27)		 1.26
(0.8, 1.97)

BMI, body mass index; CI, confidence interval; HR, hazard ratio; MI, myocardial infarction; ref: reference.

a

With adjustment of baseline covariates: randomized treatment, age, sex, hypertension, diabetes, current smoker, atrial fibrillation, dialysis at baseline, prior myocardial infarction/percutaneous coronary intervention/coronary artery bypass grafting, prior heart failure, ejection fraction, prior stroke, prior peripheral arterial disease, baseline Seattle Angina Questionnaire summary score, Canadian Cardiovascular Society Angina (I/II/III), New York Heart Association I/II/III, baseline low density lipoprotein- and high density lipoprotein-cholesterol.